XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 26, 2016
Jun. 28, 2015
Jun. 26, 2016
Jun. 28, 2015
Revenues $ 20,371 $ 18,955 $ 41,204 $ 38,132
Cost of products sold 14,471 13,096 28,899 26,266
Gross profit 5,900 5,859 12,305 11,866
Operating expenses:        
Research and development 1,425 1,334 3,081 2,693
Selling, general and administrative 3,976 3,708 8,243 7,534
Total operating expenses 5,401 5,042 11,324 10,227
Operating income 499 817 981 1,639
Other (expense) income:        
Interest and financing expense (62) (64) (163) (130)
Miscellaneous 38 92 26 (30)
Income before income taxes 475 845 844 1,479
Income tax provision 33 71 121 182
Net income 442 774 723 1,297
Net loss attributable to non-controlling interest 4 14 22 24
Net income attributable to Ultralife Corporation 446 788 745 1,321
Other Comprehensive (loss) income:        
Foreign currency translation adjustments (422) 44 (701) 66
Comprehensive income attributable to Ultralife Corporation $ 24 $ 832 $ 44 $ 1,387
Net income per share attributable to Ultralife common shareholders – basic (in dollars per share) $ 0.03 $ 0.05 $ 0.05 $ 0.08
Net income per share attributable to Ultralife common shareholders – diluted (in dollars per share) $ 0.03 $ 0.05 $ 0.05 $ 0.08
Weighted average shares outstanding – basic (in shares) 15,258 16,557 15,290 16,945
Potential common shares (in shares) 161 40 255 32
Weighted average shares outstanding - diluted (in shares) 15,419 16,597 15,545 16,977